Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

12871 ARTÍCULOS , VIENDO DEL 2446 AL 2460

Expanding the etiologic spectrum of spastic ataxia syndrome: chronic infection with human T lymphotropic virus type 1

Edhom KA, Lidman C, Granberg T, Taylor GP, Paucar M.

J Neurovirol. 2021 Apr;27(2):345-347. doi: 10.1007/s13365-020-00932-2. Epub 2021 Mar 22.

PICA injury secondary to anterior odontoid screw fixation: Case report of an exceptional complication

Farah K, Meyer M, Reyre A, Cot K, Fuentes S.

Neurochirurgie. 2021 Jul;67(4):310-314. doi: 10.1016/j.neuchi.2021.02.015. Epub 2021 Mar 19.

Sensory Axonopathy Associated With Vitamin E Deficiency

Chan KH, O'Sullivan M, Farouji I, Are G, Slim J.

Cureus. 2021 Feb 17;13(2):e13389. doi: 10.7759/cureus.13389.

Novel SPTBN2 gene mutation and first intragenic deletion in early onset spinocerebellar ataxia type 5

Romaniello R, Citterio A, Panzeri E, Arrigoni F, De Rinaldis M, Trabacca A, Bassi MT.

Ann Clin Transl Neurol. 2021 Apr;8(4):956-963. doi: 10.1002/acn3.51345. Epub 2021 Mar 23.

A narrative review on non-invasive stimulation of the cerebellum in neurological diseases

Billeri L, Naro A.

Neurol Sci. 2021 Jun;42(6):2191-2209. doi: 10.1007/s10072-021-05187-1. Epub 2021 Mar 23.

Generation of spinocerebellar ataxia type 3 patient-derived induced pluripotent stem cell line (CSUXHi005-A) from human urine epithelial cells

He L, Han X, Zhao H, Li S, Chen Z, Wang C, Wang S, Peng L, Deng W, Li Z, Tang B, Jiang H.

Stem Cell Res. 2021 May;53:102289. doi: 10.1016/j.scr.2021.102289. Epub 2021 Mar 17.

Subacute cerebellar ataxia following respiratory symptoms of COVID-19: a case report

Werner J, Reichen I, Huber M, Abela IA, Weller M, Jelcic I.

BMC Infect Dis. 2021 Mar 24;21(1):298. doi: 10.1186/s12879-021-05987-y.

Post-COVID-19 Acute Disseminated Encephalomyelitis in a 17-Month-Old

McLendon LA, Rao CK, Da Hora CC, Islamovic F, Galan FN.

Pediatrics. 2021 Jun;147(6):e2020049678. doi: 10.1542/peds.2020-049678. Epub 2021 Mar 24.

[A case of brain tuberculoma resembling a malignant tumor]

Shiraishi W, Tateishi T, Sonoda K, Yamasaki R, Kira JI.

Rinsho Shinkeigaku. 2021 Apr 21;61(4):253-257. doi: 10.5692/clinicalneurol.cn-001557. Epub 2021 Mar 25.

Safety and tolerability of escalating cannabinoid doses in healthy cats

Kulpa JE, Paulionis LJ, Eglit GM, Vaughn DM.

J Feline Med Surg. 2021 Dec;23(12):1162-1175. doi: 10.1177/1098612X211004215. Epub 2021 Mar 26.

Progression characteristics of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS): a 4-year cohort study

Reetz K, Dogan I, Hilgers RD, Giunti P, Parkinson MH, Mariotti C, Nanetti L, Durr A, Ewenczyk C, Boesch S, Nachbauer W, Klopstock T, Stendel C, Rodríguez de Rivera Garrido FJ, Rummey C, Schöls L, Hayer SN, Klockgether T, Giordano I, Didszun C, Rai M, Pandolfo M, Schulz JB; EFACTS study group.

Lancet Neurol. 2021 May;20(5):362-372. doi: 10.1016/S1474-4422(21)00027-2. Epub 2021 Mar 23.

A novel homozygous splice-site mutation in SCARB2 is associated with progressive myoclonic epilepsy with renal failure

Yari A, Ali-Nejad RM, Saleh-Gohari N.

Neurol Sci. 2021 Dec;42(12):5077-5085. doi: 10.1007/s10072-021-05196-0. Epub 2021 Mar 26.

Clinical and biochemical footprints of inherited metabolic disease. V. Cerebral palsy phenotypes

Horvath GA, Blau N, Ferreira CR.

Mol Genet Metab. 2022 Dec;137(4):445-448. doi: 10.1016/j.ymgme.2021.03.008. Epub 2021 Mar 13.

The Molecular Function of PURA and Its Implications in Neurological Diseases

Molitor L, Bacher S, Burczyk S, Niessing D.

Front Genet. 2021 Mar 11;12:638217. doi: 10.3389/fgene.2021.638217. eCollection 2021.

Opsoclonus-myoclonus-ataxia syndrome in children

Bhatia P, Heim J, Cornejo P, Kane L, Santiago J, Kruer MC.

J Neurol. 2022 Feb;269(2):750-757. doi: 10.1007/s00415-021-10536-3. Epub 2021 Mar 29.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias